Amyotrophic Lateral Sclerosis (ALS)
The Forbes Norris MDA/ALS Research Center
| Principal Investigator/Contact Information | Protocol Title | Patient Population | Recruitment Period |
| Principal Investigator: Robert Miller, MD Contact: Stacey Champion 415-600-3967 | Monitoring immune parameter effects of in vitro drug treatment on blood cells of patients with Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (AD) | Subjects diagnosed with Amyotrophic Lateral Sclerosis and subjects diagnosed with Mild Cognitive Impairment, Mild Alzheimer's Disease, or Vascular Dementia | Open |
| Principal Investigator: Jonathan Katz, MD Contact: Marguerite Engel 415-600-3758 | Clinical Trial of Ceftriaxone in Subjects with ALS | Subjects diagnosed with Amyotrophic Lateral Sclerosis whose symptoms started within the past three years and have a breathing capacity of 60% or greater | Open |
updated: 9/15/09